The Top 10 pharma markets in the vast Asia-Pacific region, ranked by market size in USD millions for 2018. China is way out in front with a market…

The latest from Spanish pharma, including the acquisition of PTS by a private equity group for its nanoparticle drug delivery technologies; the…

The SXI Bio & MedTech Index outperformed the Swiss Performance Index (SPI) by 38 percent and NASDAQ Biotech by 46 per cent between 2015 and 2020.…

The top 10 fastest-growing private pharma companies in the UK for 2021, compiled by corporate finance advisory firm Alantra. Featured companies…

The full list of medicines recommended for approval by the European Medicines Agency (EMA) in 2020 divided by therapeutic area and with drugs that…

Following on from our recent compilations of 2020 new drug approvals in the USA, China, and Switzerland, see below for the Japanese PMDA's new drug…

The Chinese NMPA’s drug approval list for 2020 includes a surge in approvals for locally developed drugs. A total of 46 new drugs were approved in…

Regarded as one of the world’s leading regulatory bodies, Swissmedic stands alongside its equivalents in Europe, Japan, Canada, and Australia in…

In 2020, the US FDA's Center for Drug Evaluation & Research (CDER) approved 53 novel drugs, up from 48 in 2019, across a range of therapeutic…

The Top 15 pharma companies in the Central America & Caribbean (CENCA) region's retail market (Rx & OTC) for 2019 ranked by sales in USD…

Following on from our list of the overall top 10 companies in the Saudi Arabian pharma market, here PharmaBoardroom highlights some of the top…

In a recent article for PharmaBoardroom, Objective Capital's David Crean took a look at the state of US innovation today and its long term…